The independent source for health policy research, polling, and news.
7,481-7,500 of 112,980 results
In response to an earlier inspection by the FDA of what Stat calls a "troubled plant," a recent warning letter was sent alleging that Intas employees tried to destroy manufacturing documents and that an employee failed to report all test results on product samples. Also in the news: a birth control pill recall and more.
The lawsuit alleges UnitedHealth's UMR unit denied thousands of medical claims without reviewing them for medical necessity. Separately, employers are fighting for billing data that health insurers won't reveal. Also in the news: rising prices at independent hospitals.
The cells, known as HeLa, had "remarkable properties" allowing endless reproduction for medical research purposes, NPR explains, but they were taken without Henrietta Lacks' consent in 1950s. The settlement was reached with her family on what would have been her 103rd birthday.
The drugmaker's CEO Albert Bourla revealed he thinks the FDA could authorize updated covid boosters by the end of the month during an investor call. Separately, CNN reports that vaccines for flu and RSV are being rolled out to major pharmacy chains ahead of the fall respiratory virus season.
In April, CMS proposed a 2.8% boost in reimbursements for fiscal 2024. But the agency said Tuesday that it would be 3.1% net increase. In other news, the Blackfeet Tribe of Montana has declared a public health state of emergency over a Medicaid scam.
Two new reports from March of Dimes and Milken Institute detail the deteriorating quality of care for pregnant women, which is particularly concerning as abortion access is cut off in many states.
Indiana's law -- that's on pause again -- bans all surgical abortions at any point in the pregnancy, with limited exceptions for health risks for the mother or in cases or rape or incest. The state's six abortion clinics stopped offering services yesterday.
Today's early morning highlights from the major news organizations.
Editorial writers discuss heat waves, long covid, superbugs and more.
AP reports on the decision from the Sixth U.S. Circuit Court of Appeals in Cincinnati, which it calls "not unexpected" since the same court ruled a similar way earlier this month on a case in Tennessee. Meanwhile, a story in Stat covers how primary care doctors are learning about trans health.
The disease, also called Hansen's disease, is contagious but curable. The CDC has advised physicians across the United States to consider whether a patient traveled to Florida when conducting disease tracing. Other news is on mpox, smallpox, and hepatitis C.
A U.S. judge temporarily barred Idaho Attorney General Raul Labrador from prosecuting medical professionals for referring patients for an abortion in a state where the procedure is legal. And a similar legal challenge was filed in Alabama, as well.
The newest rankings have dropped the numbering system and instead list an "honor roll" in no particular order. Despite years of controversy surrounding the rankings, one patient-safety expert told USA Today that the rankings are one of the only sources of up-to-date data that patients have to compare hospitals in a comprehensible and transparent way.
Stat says that even though five elderly people were blinded in one eye after receiving injections of the newly-approved treatment, the cause remains unknown. In other news: CVS will cut 5,000 jobs to reduce costs, interest in a new cancer-detecting blood test, and more.
The Washington Post shines a spotlight on how marijuana addiction is sometimes met with "derision," amid unclear science over benefits, harms. Meanwhile, ABC News says doctors are discouraging vaping as data mounts over health impacts, even when used as an anti-smoking tool.
The White House announced Monday its new Office of Long COVID Research and Practice that will study a condition that is estimated to impact millions, and to coordinate any federal response. And NIH says that it will start the first clinical trial to study the use of Paxlovid as a long covid treatment.
The Biden administration's new Medicare pilot program has a goal of improving quality of life of people with dementia and reducing burdens on unpaid carers. But Stat notes that the program does not aim at controlling the price of new Alzheimer's medications.
The Centers for Medicare and Medicaid Services warned an “unauthorized party" exploited a security vulnerability that gave them access to the data. Meanwhile, the agency is working to to smooth "conflicting" rules on data sharing during the prior authorization process.
Today's early morning highlights from the major news organizations.
Editorial writers tackle these public health issues.
© 2026 KFF